Your browser doesn't support javascript.
loading
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Kim, Youn H; Prince, H Miles; Whittaker, Sean; Horwitz, Steven M; Duvic, Madeleine; Bechter, Oliver; Sanches, Jose A; Stadler, Rudolf; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Eradat, Herbert; Pinter-Brown, Lauren C; Ortiz-Romero, Pablo L; Akilov, Oleg E; Trotman, Judith; Taylor, Kerry; Weichenthal, Michael; Walewski, Jan; Fisher, David; McNeeley, Marise; Gru, Alejandro A; Brown, Lisa; Palanca-Wessels, M Corinna; Lisano, Julie; Onsum, Matthew; Bunn, Veronica; Little, Meredith; Trepicchio, William L; Dummer, Reinhard.
  • Kim YH; Dermatology and Medicine, Stanford University School of Medicine and Cancer Institute, 780 Welch Road, CJ220D, 94305, Stanford, CA, USA. Electronic address: younkim@stanford.edu.
  • Prince HM; Department of Haematology, University of Melbourne, 140 Clarendon Street, 3002, East Melbourne, Australia. Electronic address: Miles.prince@petermac.org.
  • Whittaker S; St Johns Institute of Dermatology, Guys and St Thomas NHS Foundation Trust, St Thomas Street, SE1 7EL, London, UK. Electronic address: Sean.whittaker@kcl.ac.uk.
  • Horwitz SM; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10065, New York, NY, USA. Electronic address: horwitzs@mskcc.org.
  • Duvic M; Department of Dermatology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1452, 77030, Houston, TX, USA. Electronic address: mduvic@mdanderson.org.
  • Bechter O; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. Electronic address: oliver.bechter@uzleuven.be.
  • Sanches JA; Department of Dermatology, University of São Paulo Medical School, Av. Dr. Enéas de Carvalho Aguiar 255, S. 3068, 05403-000, São Paulo, Brazil. Electronic address: jasanchesjr@gmail.com.
  • Stadler R; University Clinic for Dermatology, Johannes Wesling Medical Centre, Hans-Nolte-Str. 1, D-32429, Minden, Germany. Electronic address: rudolf.stadler@t-online.de.
  • Scarisbrick J; Department of Dermatology, Cutaneous Lymphoma Service, University Hospital Birmingham, Mindelsohn Way, B15 2TH, Birmingham, UK. Electronic address: Julia.Scarisbrick@uhb.nhs.uk.
  • Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Via Cherasco 23, 10126, Turin, Italy. Electronic address: Pietro.quaglino@unito.it.
  • Zinzani PL; Institute of Hematology 'Seràgnoli', University of Bologna, Via Massarenti 9, 40138, Bologna, Italy. Electronic address: pierluigi.zinzani@unibo.it.
  • Wolter P; Department of Internal Medicine/Medical Oncology, Klinik St. Josef, St Vith, Klosterstrasse 9, 4780, St Vith, Belgium. Electronic address: pascalwolter@hotmail.com.
  • Eradat H; Department of Hematology-Oncology, David Geffen School of Medicine at UCLA, 2020 Santa Monica Blvd Suite 600, 90404, Los Angeles, CA, USA. Electronic address: Heradat@mednet.ucla.edu.
  • Pinter-Brown LC; Internal Medicine, Division of Hematology-Oncology, Chao Family Comprehensive Cancer Center, University of California, 101 The City Drive, 92868, Irvine, CA, USA. Electronic address: lpinterb@uci.edu.
  • Ortiz-Romero PL; Department of Dermatology, Hospital 12 de Octubre. Institute I+12. Medical School. University Complutense, Av Córdoba s/n, 28041, Madrid, Spain. Electronic address: portiz.hdoc@salud.madrid.org.
  • Akilov OE; Department of Dermatology, University of Pittsburgh, 200 Lothrop Street, 15213, Pittsburgh, PA, USA. Electronic address: akilovoe@upmc.edu.
  • Trotman J; Department of Hematology, Concord Repatriation General Hospital, University of Sydney, Hospital Road, 2139, Concord, Sydney, Australia. Electronic address: judith.trotman@sswahs.nsw.gov.au.
  • Taylor K; Department of Hematology, ICON Cancer Care, 293 Vulture Street, 4101, South Brisbane, Australia. Electronic address: ktaylor@iconcancercare.com.au.
  • Weichenthal M; Department of Dermatology, University Hospital of Schleswig-Holstein, Arnold Heller Str.3, 24105, Kiel, Germany. Electronic address: MWeichenthal@dermatology.uni-kiel.de.
  • Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 5 W. K. Roentgen, 02-781, Warsaw, Poland. Electronic address: jan.walewski@coi.pl.
  • Fisher D; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, 02215, Boston, MA, USA. Electronic address: David_C_fisher@dfci.harvard.edu.
  • McNeeley M; Department of Anatomic Pathology for Clinical Trials, Quest Diagnostics, 1 Malcolm Avenue, 07608, Teterboro, NJ, USA. Electronic address: Marise.McNeeley@gmail.com.
  • Gru AA; Department of Pathology, University of Virginia, School of Medicine, 2730 Hunt Country Ln, 22901, Charlottesville, VA, USA. Electronic address: AAG4B@hscmail.mcc.virginia.edu.
  • Brown L; Seagen Inc, 21823 30th Drive Southeast, 98021, Bothell, WA, USA. Electronic address: lisaannebr@gmail.com.
  • Palanca-Wessels MC; Seagen Inc, 21823 30th Drive Southeast, 98021, Bothell, WA, USA. Electronic address: cpalanca@seagen.com.
  • Lisano J; Seagen Inc, 21823 30th Drive Southeast, 98021, Bothell, WA, USA. Electronic address: jlisano@seagen.com.
  • Onsum M; Seagen Inc, 21823 30th Drive Southeast, 98021, Bothell, WA, USA. Electronic address: monsum@seagen.com.
  • Bunn V; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, 40 Landsdowne Street, 02139, Cambridge, MA, USA. Electronic address: Veronica.Bunn@takeda.com.
  • Little M; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, 40 Landsdowne Street, 02139, Cambridge, MA, USA. Electronic address: meredith.little@takeda.com.
  • Trepicchio WL; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, 40 Landsdowne Street, 02139, Cambridge, MA, USA. Electronic address: bill.trepicchio@takeda.com.
  • Dummer R; Department of Dermatology, Skin Cancer Center, University Hospital Zürich, Gloriastrasse 31, 8091, Zürich, Switzerland. Electronic address: Reinhard.Dummer@usz.ch.
Eur J Cancer ; 148: 411-421, 2021 05.
Article en En | MEDLINE | ID: mdl-33794441
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Médicos / Conducta de Elección / Técnicas de Apoyo para la Decisión / Micosis Fungoide / Antígeno Ki-1 / Antineoplásicos Inmunológicos / Brentuximab Vedotina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Médicos / Conducta de Elección / Técnicas de Apoyo para la Decisión / Micosis Fungoide / Antígeno Ki-1 / Antineoplásicos Inmunológicos / Brentuximab Vedotina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article